Table 1.
Polyphenol | Study Type | Study Model | Effects | Targets | Ref. |
---|---|---|---|---|---|
EGCG + metformin | In vitro | B16F10 cells | Inhibition of cell growth and STAT3/NF-κb pathway | STAT3 and NF-κb p65 ↓ | [81] |
Curcumin | In vivo | BK5.IGF-1 transgenic (Tg) mice | Inhibition of tumor growth | IGF-1 ↓ | [83] |
Genistein | In vitro | B16F10 melanoma cells | Inhibition of cell proliferation, migration, and metastasis | p-p38, p-ERK, and p-JNK ↓ | [86] |
Quercetin | In vitro | B16 and A375 cells | Suppressed proliferation | RIG-I ↑ IFN-I ↑ STAT1 ↑ |
[89] |
EGCG | In vivo | C57BL/6 mice | Inhibition of tumor growth | STAT1 ↓ | [90] |
Rosmarinic acid | In vitro | A375 | Inhibits proliferation and migration | ADAM17/EGFR/AKT/GSK3β ↓ | [84] |
Luteolin | In vitro | A375 | Inhibited the proliferation, migration, and invasion | MMP-2 and MMP-9 ↓ TIMP-1 and TIMP-2 ↑ |
[94] |
Apigenin | In vivo | WT mice TKO mice |
Inhibition of UV-induced cutaneous angiogenesis | TSP-1 ↑ | [106] |
Caffeic acid | In vivo | Male Swiss albino mice | Inhibition of angiogenesis and proliferation | TSP-1 ↑ | [102] |
Resveratrol | In vitro | Co-culture | Antiangiogenic effects | VEGF ↓ TSP-1 ↑ |
[96] |
EGCG | In vitro | 1205Lu, HS294T, and A375 cells | Inhibition of cell proliferation | STAT1 ↓ | [90] |
Herbacetin | In vitro | A375 and Hs294T cells | Suppressed angiogenesis | MMP9 ↓ | [105] |